• News
  • SAN DIEGO
  • BioTech

Halozyme gains on $4 million payment by Roche

Halozyme Therapeutics Inc. gained after a filing by partner Roche Holding AG with European regulators triggered a $4 million milestone payment.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!